Table 1.
Baseline characteristics of all CD patients (n = 114)
| All CD patients, (n = 114), n (%) | Inflammatory disease (n = 54), n (%) | Complicated disease, (n = 60), n (%) | p value | |
|---|---|---|---|---|
| Male | 60 (52.6) | 30 (55.6) | 30 (50.0) | 0.55 |
| Age at baseline (years), median, [IQR] | 35.50 [27.0–46.3] | 38.50 [26.8–47.3] | 33.00 [27.0–45.0] | 0.91 |
| Age at diagnosis (years), median, [IQR] | 26.00 [17.0–36.0] | 28.00 [17.0–35.3] | 25.50 [17.0–36.8] | 0.84 |
| Age of onset | ||||
| A1 | 24 (21.1) | 11 (20.4) | 13 (21.7) | 0.87 |
| A2 | 69 (60.5) | 35 (64.8) | 34 (56.7) | 0.37 |
| A3 | 21 (18.4) | 8 (14.8) | 13 (21.7) | 0.35 |
| Current drug therapya | ||||
| Corticosteroids | 36 (31.6) | 19 (35.9) | 17 (28.3) | 0.27 |
| Biological therapy | 22 (19.3) | 11 (20.4) | 11 (18.3) | 0.63 |
| Immunomodulator | 25 (21.9) | 14 (25.9) | 11 (18.3) | 0.22 |
| 5-aminosalicylic acid | 14 (12.3) | 5 (9.2) | 9 (15.0) | 0.41 |
| Current smoker | 13 (11.4) | 6 (11.1) | 7 (11.7) | 0.93 |
| CRP (<5 ng/mL) | 88 (77.2) | 40 (74.1) | 48 (80.0) | 0.45 |
| BMI (kg/m2), median, [IQR] | 21.94 [19.4–24.9] | 21.32 [18.8–35.3] | 22.21 [19.5–25.2] | 0.50 |
| BMI <18.5 kg/m2 | 20 (17.5) | 11 (20.4) | 9 (15.0) | 0.45 |
| BMI 18.5-24.9 kg/m2 | 68 (59.6) | 32 (59.3) | 36 (60.0) | 0.94 |
| BMI >25 kg/m2 | 26 (22.8) | 11 (20.4) | 15 (25.0) | 0.56 |
Continuous variables are reported as median and interquartile range (IQR). CD, Crohn's disease; CRP, C-reactive, protein; BMI, body mass index.
a
Current therapy information was available for 99 patients only.